Cargando…

A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis

BACKGROUND: Treatment failures (TFs) generally exist in the course of ulcerative colitis (UC), while early reliable predictors of TFs are still lacking. We aimed to generate nomograms for the prediction of TFs. METHODS: In this retrospective case–control study, the endpoint was the occurrence of TFs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ying, Huang, Xuanzhi, Zhou, Gaoshi, Han, Jing, Xie, Zhuo, Zhang, Mudan, Li, Xiaoling, Wu, Qi-rui, Li, Li, Ye, Ziyin, Chen, Minhu, Qiu, Yun, Zhang, Shenghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162100/ https://www.ncbi.nlm.nih.gov/pubmed/37152865 http://dx.doi.org/10.2147/JIR.S410057

Ejemplares similares

Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis
por: Fang, Jian, et al.
Publicado: (2021)

Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis
por: Chen, Rirong, et al.
Publicado: (2023)

Can fecal calprotectin accurately identify histological activity of ulcerative colitis? A meta-analysis
por: Ye, Xiaoqi, et al.
Publicado: (2021)

Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease
por: Xie, Zhuo, et al.
Publicado: (2021)

Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice
por: Lin, Lihui, et al.
Publicado: (2022)

Role of Rho GTPases in inflammatory bowel disease
por: Li, Xiaoling, et al.
Publicado: (2023)

Recent developments on BMPs and their antagonists in inflammatory bowel diseases
por: Xie, Zhuo, et al.
Publicado: (2023)

Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis
por: van der Post, Sjoerd, et al.
Publicado: (2019)

Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area
por: Xu, Shu, et al.
Publicado: (2020)

Fecal lactoferrin early predicts long‐term outcomes in ulcerative colitis: A post‐hoc analysis of the UNIFI and PURSUIT trials
por: Chen, Rirong, et al.
Publicado: (2023)

Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis
por: Ke, Haoran, et al.
Publicado: (2021)

Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
por: Huang, Shanshan, et al.
Publicado: (2023)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease
por: Zhuang, Xiaojun, et al.
Publicado: (2022)

A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021)

Risk factors and long-term outcome of disease extent progression in Asian patients with ulcerative colitis: a retrospective cohort study
por: Qiu, Yun, et al.
Publicado: (2019)

Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
por: Zhou, Gaoshi, et al.
Publicado: (2022)

Development and validation of a nomogram to predict indolent course in patients with ulcerative colitis: a single-center retrospective study
por: Li, Na, et al.
Publicado: (2022)

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease
por: Chen, Rirong, et al.
Publicado: (2020)

Mucus-Penetrating Silk Fibroin-Based Nanotherapeutics for Efficient Treatment of Ulcerative Colitis
por: Xie, Dengchao, et al.
Publicado: (2022)

A15 GENETIC OR DIET-ASSOCIATED DEFECTS IN MUCUS FACILITATE ULCERATIVE COLITIS PATHOBIONT-DRIVEN COLITIS
por: Yang, H, et al.
Publicado: (2023)

Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
por: Lin, Lihui, et al.
Publicado: (2020)

Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn’s disease
por: Zhou, Longyuan, et al.
Publicado: (2023)

Colonisation of the colonic mucus gel layer with butyrogenic and hydrogenotropic bacteria in health and ulcerative colitis
por: Earley, Helen, et al.
Publicado: (2021)

Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis
por: Johansson, Malin E V, et al.
Publicado: (2014)

The Cervicovaginal Mucus Barrier
por: Lacroix, Guillaume, et al.
Publicado: (2020)

Comparing the clinical application values of the Degree of Ulcerative Colitis Burden of Luminal Inflammation (DUBLIN) score and Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in patients with ulcerative colitis
por: Zhang, Xiao-Fei, et al.
Publicado: (2021)

Comparative study between histochemical mucus volume, histopathological findings, and endocytoscopic scores in patients with ulcerative colitis
por: Kamitani, Yu, et al.
Publicado: (2023)

Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3
por: Li, Manying, et al.
Publicado: (2017)

Nomogram for Prediction of Bronchial Mucus Plugs in Children with Mycoplasma pneumoniae Pneumonia
por: Xu, Xuefeng, et al.
Publicado: (2020)

Milk Fat Globule Membrane Attenuates Acute Colitis and Secondary Liver Injury by Improving the Mucus Barrier and Regulating the Gut Microbiota
por: Wu, Zhenhua, et al.
Publicado: (2022)

Maltodextrin Consumption Impairs the Intestinal Mucus Barrier and Accelerates Colitis Through Direct Actions on the Epithelium
por: Zangara, Megan T., et al.
Publicado: (2022)

Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease
por: Chen, Peng, et al.
Publicado: (2021)

Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity
por: Belvis Jiménez, María, et al.
Publicado: (2021)

Lipid Based Therapy for Ulcerative Colitis—Modulation of Intestinal Mucus Membrane Phospholipids as a Tool to Influence Inflammation
por: Schneider, Hannah, et al.
Publicado: (2010)

Lycopene, Lutein and Zeaxanthin May Reduce Faecal Blood, Mucus and Pus but not Abdominal Pain in Individuals with Ulcerative Colitis
por: Głąbska, Dominika, et al.
Publicado: (2016)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

Mucus-Penetrating Particles and the Role of Ocular Mucus as a Barrier to Micro- and Nanosuspensions
por: Popov, Alexey
Publicado: (2020)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
por: Travis, Simon P L, et al.
Publicado: (2011)

Cohousing-mediated microbiota transfer from milk bioactive components-dosed mice ameliorate colitis by remodeling colonic mucus barrier and lamina propria macrophages
por: Liu, Cong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dr0dnbb6hh64j7i22t0uu9p0i4